Reimbursement and Access 2019

Reimbursement and Access 2019 August 13-14, 2019 | DoubleTree by Hilton Center City | Philadelphia, PA www.cbinet.com/Reimbursement For all companies within the life sciences arena, staying on the pulse of emerging trends, ensuring favorable reimbursement and justifying product prices are core pillars of overall product success. Whether your organization is pre-commercial or managing multiple products, CBI’s Reimbursement and Access conference convenes stakeholders from across the life sciences community to provide insight into real-time policy briefings, impactful managed markets trends and strategies to ensure product access. Drug Channels readers can register using discount code QEF679 to receive $500 off* the standard … Continue reading Reimbursement and Access 2019

A New Starting Point for Patient Support: Technology-Driven Hub Services

Today’s guest post comes from Erica Conroy, VP of Specialty at CoverMyMeds and Bill Nolan, VP/GM of Access and Adherence at RxCrossroads by McKesson. Erica and Bill discuss the challenges that specialty pharmacy patients encounter when accessing and utilizing hub services. They also present evidence showing that how hub services positively affect patient outcomes. To learn more, download CoverMyMeds’ whitepaper: Revolutionizing Patient Access and Support for Specialty Therapies: Multiple Sclerosis. Read on for their insights. Read more » Copyright © 2006-2019 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. This Feed … Continue reading A New Starting Point for Patient Support: Technology-Driven Hub Services

CBI’s Strategic Medicare Contracting Forum for Bio/Pharmaceutical Manufacturers

CBI’s Strategic Medicare Contracting Forum for Bio/Pharmaceutical Manufacturers June 19-20, 2019 | Alexandria, VA www.cbinet.com/Medicare CBI’s Strategic Medicare Contracting Forum for Bio/Pharma Manufacturers provides a real-time analysis of newly proposed regulations, including the proposal to eliminate rebates, the use of step therapy under Medicare Part B, changes to coverage gap, influence of the International Pricing Index and much more. Exclusive Offer for Drug Channels Readers: Register Now and SAVE $400* using promo code MED400. Taking place June 19-20 in Alexandria, VA, we invite you to convene with fellow stakeholders to receive an in-depth look into legislative and regulatory changes to Medicare … Continue reading CBI’s Strategic Medicare Contracting Forum for Bio/Pharmaceutical Manufacturers

Patient Support Services Congress

Patient Support Services Congress June 19-20, 2019 | Sheraton University City | Philadelphia, PA www.cbinet.com/PatientServices Join your colleagues for CBI’s Patient Support Services Congress — an industry-driven meeting, where you can participate in a wide-ranging dialogue surrounding customized patient support, operational efficiencies and compliant program services. Visit www.cbinet.com/PatientServices for more information. Drug Channels subscribers will save $250 off the standard registration rate when they use discount code DRC250* by March 1, 2019. REGISTER TODAY! A DIALOGUE-DRIVEN MEETING FOR ENFORCEMENT TRENDS AND NEXT-GENERATION APPROACHES TO PATIENT SERVICES: Examine the regulatory implications around copy cards and foundation relationships Discuss challenges in providing … Continue reading Patient Support Services Congress

Financial Strategies and Accounting for Bioscience Companies

Financial Strategies and Accounting for Bioscience Companies June 11-12, 2019 | San Francisco, CA www.cbinet.com/financialstrategies Expectations have never been higher as more small and mid-sized life science companies prepare to launch new and innovative products in a competitive marketplace. Gross-to-Net remains a top risk, especially after a launch, and it is pivotal to achieve accuracy in GTN forecasts to avoid large adjustments. Ensure success by gaining proven pre-revenue commercialization strategies, frameworks for managing gross-to-net estimates and mitigating risk, models to scale the business and grow a best-in-class finance function, hearing, timely updates on tax and legal matters, and industry expertise … Continue reading Financial Strategies and Accounting for Bioscience Companies

Help for the Patient Journey–Electronic Modernization of Medication Access

Today’s guest post comes from Ben Stormer, VP of Product Development and Strategy for Specialty at CoverMyMeds. Ben discusses how automatic, streamlined electronic enrollment in patient hub services will improve patients’ adherence to specialty medication. To learn more, connect with CoverMyMeds at the Asembia Specialty Pharmacy Summit next week in Las Vegas. Read on for Ben’s insights. Read more » Copyright © 2006-2019 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. This Feed is for personal non-commercial use only.          Powered by WPeMatico Continue reading Help for the Patient Journey–Electronic Modernization of Medication Access

CBI’s 15th Annual Commercial Contract & Chargeback Excellence

CBI’s 15th Annual Commercial Contract & Chargeback Excellence June 25-26, 2019 | Philadelphia, PA www.cbinet.com/chargebacks Heading into Year 15, CBI’s Commercial Contract & Chargeback Excellence conference has become a must-attend for pricing and contracting professionals, offering interactive dialogue and best practices to guide you through a rapidly changing market. Visit www.cbinet.com/chargebacks for further details and to register. Drug Channels readers will save $400 off the standard rate when they use discount code ZKE535 and register prior to May 10th.* Our esteemed speaking faculty, made up of companies such as Pacira Pharmaceuticals, Premier, Celgene, McKesson, Chiesi USA, Zydus Pharmaceuticals and more, … Continue reading CBI’s 15th Annual Commercial Contract & Chargeback Excellence

TrialCard: The Role of Hub Services in an Era of Drug Price Transparency, Value-Based Care, and Consumerism

Today’s guest post comes from Scott Dulitz, Chief Strategy Officer at TrialCard. Scott discusses the evolution of pharmaceutical manufacturer hub programs. As he explains, crucial industry trends are changing how patients and healthcare providers interact with and evaluate support services. To learn more about TrialCard’s patient management solution, view TrialCard’s recent video: Emerging Market Trends Shape Hub/Market Access Services, or email Scott at scott.dulitz@trialcard.com. Read on for Scott’s insights. Read more » Copyright © 2006-2019 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. This Feed is for personal non-commercial use only. … Continue reading TrialCard: The Role of Hub Services in an Era of Drug Price Transparency, Value-Based Care, and Consumerism

Rare Disease Innovation and Partnering Summit

Rare Disease Innovation and Partnering Summit June 13-14, 2019 | Boston, MA www.raredisease-summit.com As genomics and advanced diagnostics expand our understanding of rare diseases, so too does the scope of impact expand. More than 30 million Americans live with a rare disease. While the industry has seen growth and heightened focus around the pursuit of orphan products and rare therapies, we’ve only scratched the surface. CBI and EBD Group, along with support from the Alliance for Regenerative Medicine, Global Genes and MassBio, are pleased to announce the Rare Disease Innovation and Partnering Summit, a platform designed to increase chances of … Continue reading Rare Disease Innovation and Partnering Summit

Drug Price Transparency and Rebate Reform Take Center Stage

Today’s guest post comes from Kay Morgan, Vice President of Drug Information Excellence at Elsevier. Kay discusses her thoughts on the latest developments on rebate reform and drug price transparency reform. Learn more by downloading Elsevier’s white paper: Prescription Drug Transparency Reform: While You Wait. Read on for Kay’s insights. Read more » Copyright © 2006-2019 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. This Feed is for personal non-commercial use only.          Powered by WPeMatico Continue reading Drug Price Transparency and Rebate Reform Take Center Stage